Drug
C1 Esterase Inhibitor
C1 Esterase Inhibitor: highest development phase Phase 3, developed by CSL. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| C1-esterase inhibitor NCT03221842 | Phase 3 | Antibody-mediated Rejection |
| C1 Esterase Inhibitor NCT00292981 | Phase 3 | Hereditary Angioedema |
Latest
No recent events.
Follow C1 Esterase Inhibitor on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.